MCID: MCR191
MIFTS: 53

Microscopic Colitis malady

Categories: Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Microscopic Colitis

About this section
Sources:
10Disease Ontology, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet
See all MalaCards sources

Aliases & Descriptions for Microscopic Colitis:

Name: Microscopic Colitis 10 12 51
 
Colitis, Microscopic 36 65

Characteristics:

Orphanet epidemiological data:

51
microscopic colitis:
Prevalence: 1-9/100000 (Europe); Age of onset: Adult; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology10 DOID:0060182
MeSH36 D046728
NCIt42 C38504
Orphanet51 58220
SNOMED-CT59 235753003
UMLS via Orphanet66 C0400821
ICD10 via Orphanet28 K52.8
MESH via Orphanet37 D046728
UMLS65 C0400821

Summaries for Microscopic Colitis

About this section
Wikipedia:68 Microscopic colitis refers to two related medical conditions which cause diarrhea: collagenous colitis... more...

MalaCards based summary: Microscopic Colitis, also known as colitis, microscopic, is related to collagenous colitis and colitis. An important gene associated with Microscopic Colitis is CD79A (CD79a Molecule), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and SIDS Susceptibility Pathways. Affiliated tissues include colon, lung and liver, and related mouse phenotypes are renal/urinary system and tumorigenesis.

Disease Ontology:10 A colitis that can only be diagnosed by the examination of colon tissue under a microscope.

Related Diseases for Microscopic Colitis

About this section

Diseases related to Microscopic Colitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 266)
idRelated DiseaseScoreTop Affiliating Genes
1collagenous colitis27.9CD79A, HLA-DRB1, IFNG, IL2, IL4, IL6
2colitis10.8
3congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome10.7HLA-DRB1, TNF
4microsomia hemifacial radial defects10.7HLA-DRB1, TNF
5autoimmune polyglandular syndrome type 210.7HLA-DRB1, TNF
6best1 retinopathy10.7HLA-DRB1, TNF
7pityriasis rosea10.7CD79A, HLA-DRB1
8androgen insensitivity syndrome, mild10.7HLA-DRB1, TNF
9drug-induced mental disorder10.7HLA-DRB1, TNF
10rhizomelic dysplasia patterson lowry type10.7HLA-DRB1, TNF
11lymphocytic colitis10.7
12meckel's diverticulum10.6CD79A, LYZ
13noonan-like/multiple giant cell lesion syndrome10.6HLA-DRB1, TNF
14lymphocytic choriomeningitis10.6HLA-DRB1, TNF
15moderately severe hemophilia a10.6HLA-DRB1, TNF
16hypercalcemic sarcoidosis10.6LYZ, TNF
17rhinoscleroma10.6LYZ, TNF
18subacute glomerulonephritis10.6CD79A, LYZ
19tuberculous uveitis10.6LYZ, TNF
20crescentic glomerulonephritis10.5CD79A, LYZ
21ureterocele10.5IL2, TNF
22cogan-reese syndrome10.5CD79A, TNF
23plantar nerve lesion10.5IL6, TNF
24intermediate dend syndrome10.5IL6, TNF
25crohn's disease10.5IL6, TNF
26plasma protein metabolism disease10.5CD79A, IL6
27endometrial stromal sarcoma10.5CD79A, TNF
28malignant sertoli-leydig cell tumor of ovary10.5IL6, TNF
29cholecystitis10.5CD79A, IL2
30hemosiderosis10.5CD79A, LYZ
31mammary paget's disease10.5IL6, TNF
32inflammatory leiomyosarcoma10.5HLA-DRB1, IL6
33retinal drusen10.5CD79A, IL2
34posterior valve urethra10.5IL6, TNF
35t cell immunodeficiency primary10.5IL6, TNF
36intestinal impaction10.5CD79A, IL6
37residual stage angle-closure glaucoma10.4IL6, TNF
38precursor b lymphoblastic lymphoma/leukemia10.4IL6, TNF
39paranoid schizophrenia10.4IL6, TNF
40dysgammaglobulinemia10.4CD79A, IL4
41ischemic optic neuropathy10.4IL6, TNF
42egg allergy10.4CD79A, IL4
43primary progressive freezing gait10.4IL4, TNF
44angioid streaks10.4HLA-DRB1, IL2
45hemorrhagic fever with renal syndrome10.4HLA-DRB1, IL4
46optic neuritis10.4CD79A, IL6
47kearns-sayre syndrome10.4IL4, TNF
48cervical incompetence10.4CD79A, LYZ
49ocular muscular dystrophy10.4CD79A, IL4
50craniofacioskeletal syndrome10.4CD79A, IL4

Graphical network of the top 20 diseases related to Microscopic Colitis:



Diseases related to microscopic colitis

Symptoms for Microscopic Colitis

About this section

Drugs & Therapeutics for Microscopic Colitis

About this section

Drugs for Microscopic Colitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
InfliximabapprovedPhase 4349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
2Antirheumatic AgentsPhase 4, Phase 2, Phase 38496
3Gastrointestinal AgentsPhase 46401
4Dermatologic AgentsPhase 44555
5
BudesonideapprovedPhase 3, Phase 238151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
6glucocorticoidsPhase 3, Phase 23896
7Respiratory System AgentsPhase 3, Phase 23931
8Bronchodilator AgentsPhase 3, Phase 22377
9Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 29988
10HormonesPhase 3, Phase 211748
11Hormone AntagonistsPhase 3, Phase 210002
12Analgesics, Non-NarcoticPhase 2, Phase 35184
13AnalgesicsPhase 2, Phase 39358
14Anti-Asthmatic AgentsPhase 3, Phase 22796
15Anti-Inflammatory AgentsPhase 2, Phase 38478
16Anti-Inflammatory Agents, Non-SteroidalPhase 2, Phase 33549
17Peripheral Nervous System AgentsPhase 2, Phase 318510
18MesalaminePhase 2, Phase 315289-57-6
19
Glatiramer Acetateapproved, investigationalPhase 294147245-92-93081884
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
 
Copolymer-1
Copoylmer 1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
TV 5010
TV-5010
TV5010
Teva brand of copolymer 1
UNII-5M691HL4BO
acetic acid
20Immunosuppressive AgentsPhase 210422
21Immunologic FactorsPhase 218483
22Adjuvants, ImmunologicPhase 21783
23
Adalimumabapproved443331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
24
methylene blue71
Synonyms:
Urolene Blue
aniline violet
 
methylthionine chloride
methylthioninium chloride
methylthioninium chloride Proveblue
tetrametylthionine chloride
25Tolonium Chloride8
26Pharmaceutical Solutions7004
27
Bismuth1037440-69-916682734, 105143
Synonyms:
17034_FLUKA
24267-48-9
25243-76-9
264008_ALDRICH
265462_ALDRICH
265470_ALDRICH
452386_ALDRICH
556130_ALDRICH
7440-69-9
83Bi
95372_ALDRICH
95372_FLUKA
95375_FLUKA
AC1NSDYX
AC1O4PN8
AR-1I0647
BISMUTH, 99.95%
 
BISMUTH, 99.999%
Bi
Bismut
Bismuth standard for AAS
Bismuth standard for ICP
Bismuth(III) nitrate solution
Bismuth, elemental
Bismuth-209
C15471
CHEBI:33301
CID5359367
EINECS 231-177-4
HSDB 2078
LS-44708
LTBB002773
MolPort-003-925-759
Wismut
bismuth
bismuto
28Anti-Ulcer Agents1453
29Antacids1453
30ColaNutraceutical1768

Interventional clinical trials:

(show all 26)
idNameStatusNCT IDPhase
1Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative ColitisCompletedNCT01408810Phase 4
2Trial of Mesalamine for the Treatment of Active Microscopic ColitisCompletedNCT00952952Phase 2, Phase 3
3Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 3
4Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 3
5SOIBD Collagenous Colitis Maintenance StudyCompletedNCT01278082Phase 3
6Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous ColitisCompletedNCT00450086Phase 3
7Budesonide for Induction of Remission in Incomplete Microscopic ColitisRecruitingNCT02142634Phase 3
8Budesonide Versus Mesalazine Versus Placebo in Lymphocytic ColitisRecruitingNCT01209208Phase 3
9Long-Term Treatment of Collagenous Colitis With BudesonideActive, not recruitingNCT00139165Phase 3
10Budesonide Versus Placebo for the Treatment of Lymphocytic ColitisTerminatedNCT00217022Phase 2, Phase 3
11A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's DiseaseRecruitingNCT00731172Phase 2
12Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of TreatmentCompletedNCT01684514
13Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)CompletedNCT01289366
14Usefulness of Chromoendoscopy in Diagnosing Microscopic ColitisRecruitingNCT01504048
15Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)RecruitingNCT01787253
16Ussing Experiments to Evaluate the Role of Medication-induced Microscopic ColitisRecruitingNCT02303132
17Early Detection of Tumors of the Digestive Tract by Confocal EndomicroscopyRecruitingNCT02284802
18Fecal Microbiota Transplantation for C Diff InfectionRecruitingNCT01905709
19Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative ColitisRecruitingNCT02676817
20OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruitingNCT02523118
21The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel DiseaseRecruitingNCT02481687
22Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)RecruitingNCT02049775
23Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal CancerActive, not recruitingNCT01075893
24Case-Control Study to Identify Risk Factors for Microscopic ColitisEnrolling by invitationNCT01928667
25Risk Factors for Microscopic ColitisNot yet recruitingNCT02699333
26Treatment of Microscopic ColitisTerminatedNCT00184171

Search NIH Clinical Center for Microscopic Colitis


Cochrane evidence based reviews: colitis, microscopic

Genetic Tests for Microscopic Colitis

About this section

Anatomical Context for Microscopic Colitis

About this section

MalaCards organs/tissues related to Microscopic Colitis:

33
Colon, Lung, Liver, Prostate, Skin, Spleen, Kidney

Animal Models for Microscopic Colitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Microscopic Colitis:

38 (show all 13)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.2CD79A, IFNG, IL4, IL6, LYZ
2MP:00020068.1CD79A, IFNG, IL2, IL6, LYZ, TNF
3MP:00030127.9CD79A, IFNG, IL2, IL4, LYZ, TNF
4MP:00107717.9IFNG, IL4, IL6, LYZ, SLC6A4, TNF
5MP:00053707.7IFNG, IL2, IL4, IL6, LYZ, TNF
6MP:00053887.7IFNG, IL2, IL4, IL6, LYZ, TNF
7MP:00053817.6IFNG, IL2, IL4, IL6, LYZ, TNF
8MP:00036317.5CD79A, IFNG, IL4, IL6, LYZ, SLC6A4
9MP:00053797.4IFNG, IL2, IL4, IL6, LYZ, SLC6A4
10MP:00053766.9CD79A, IFNG, IL2, IL4, IL6, LYZ
11MP:00053876.7CD79A, IFNG, IL2, IL4, IL6, LYZ
12MP:00053976.6CD79A, IFNG, IL2, IL4, IL6, LYZ

Publications for Microscopic Colitis

About this section

Articles related to Microscopic Colitis:

(show top 50)    (show all 287)
idTitleAuthorsYear
1
Distinguishing Microscopic Colitis From Irritable Bowel Syndrome. (26707680)
2016
2
Managing Microscopic Colitis: A Patient Guide. (26584603)
2016
3
Editorial: additional evidence for drug-induced microscopic colitis. (27166985)
2016
4
Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. (26913568)
2016
5
Microscopic colitis that is not so microscopic. (25922142)
2015
6
P080. Persistence and sensitivity of colonic biopsies for microscopic colitis in a regional cohort. (25717537)
2015
7
Microscopic colitis: a misnomer for a clearly defined entity? (25961440)
2015
8
Microscopic colitis (lymphocytic and collagenous), eosinophilic colitis, and celiac disease. (26034409)
2015
9
OP010. Medication-induced microscopic colitis: do recency and duration of use matter? (25718276)
2015
10
Microscopic colitis: A review of etiology, treatment and refractory disease. (26269669)
2015
11
VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial. (26462271)
2015
12
Microscopic colitis. (25925924)
2015
13
Is microscopic colitis really microscopic? (25720998)
2015
14
Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases. (25153503)
2014
15
Microscopic colitis: Common cause of unexplained nonbloody diarrhea. (24891975)
2014
16
Microscopic Colitis - Clinical and Pathologic Perspectives. (24407107)
2014
17
Smoking- and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls. (24456904)
2014
18
Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis. (25665881)
2014
19
Microscopic colitis occurring in association with hyperplastic polyps and tubulovillous adenomas: observations in 10 cases. (25143518)
2014
20
The Epidemiology of Microscopic Colitis in Olmsted County From 2002 to 2010: A Population-Based Study. (24120840)
2013
21
Microscopic colitis: a therapeutic challenge. (23801853)
2013
22
Fasting serum concentration of short-chain fatty acids in subjects with microscopic colitis and celiac disease: no difference compared with controls, but between genders. (23600961)
2013
23
Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. (22995775)
2013
24
Is microscopic colitis a drug-induced disease? (23060216)
2012
25
Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. (22704658)
2012
26
Decreased colorectal cancer and adenoma risk in patients with microscopic colitis. (21847567)
2012
27
Clinical course of microscopic colitis in a single-center cohort study. (21575884)
2011
28
Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. (21967618)
2011
29
Efficacy of anti-TNF therapies in refractory severe microscopic colitis. (22115383)
2011
30
Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype. (21527852)
2011
31
Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis. (19717133)
2009
32
Microscopic colitis: a review for the surgical endoscopist. (19865548)
2009
33
Microscopic colitis and endoscopy. (19841492)
2009
34
Microscopic colitis: a common and an easily overlooked cause of chronic diarrhoea. (18395161)
2008
35
Diagnosis and management of microscopic colitis. (19109861)
2008
36
Microscopic colitis with giant cells: a clinico-pathological review of 11 cases and comparison with microscopic colitis without giant cells. (18985521)
2008
37
Clozapine-induced microscopic colitis: a case report and review of the literature. (18004122)
2007
38
The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. (17135309)
2007
39
How much symptom overlap is there between microscopic colitis and IBS? (17438567)
2007
40
Drug consumption and the risk of microscopic colitis. (17100977)
2007
41
Autoantibody profiles in microscopic colitis. (16724988)
2006
42
Chronic diarrhoea in non collagenous microscopic colitis: therapeutic effect of cholestyramine. (15641395)
2004
43
Microscopic colitis with giant cells: a rare new histopathologic subtype? (14765272)
2004
44
Microscopic colitis. (12744549)
2003
45
Lansoprazole-associated microscopic colitis: a case series. (12425567)
2002
46
Microscopic colitis syndrome. (7615277)
1995
47
Association of lymphocytic (microscopic) colitis with tropical sprue. (8155860)
1994
48
Response to treatment of microscopic colitis. (7919463)
1994
49
Microscopic colitis, collagenous colitis, and mast cells. (2364851)
1990
50

Variations for Microscopic Colitis

About this section

Expression for genes affiliated with Microscopic Colitis

About this section
Search GEO for disease gene expression data for Microscopic Colitis.

Pathways for genes affiliated with Microscopic Colitis

About this section

Pathways related to Microscopic Colitis according to GeneCards Suite gene sharing:

(show all 41)
idSuper pathwaysScoreTop Affiliating Genes
19.3IL4, IL6
29.3IL6, SLC6A4, TNF
39.0IL4, IL6, TNF
48.8IFNG, IL6, TNF
58.8IFNG, IL6, TNF
68.8IFNG, IL6, TNF
78.8IFNG, IL6, TNF
8
Show member pathways
8.8IFNG, IL6, TNF
98.8IFNG, IL6, TNF
10
Show member pathways
8.8IFNG, IL2, TNF
11
Show member pathways
8.8IFNG, IL2, TNF
128.8HLA-DRB1, IFNG, IL2
138.7HLA-DRB1, IL2, IL6, TNF
148.6HLA-DRB1, IL4, IL6, TNF
158.6IFNG, IL2, IL6
16
Show member pathways
8.5IFNG, IL4, IL6
178.5IFNG, IL2, IL4
188.5IFNG, IL2, IL4
198.5IFNG, IL2, IL4
208.4HLA-DRB1, IFNG, IL6, TNF
218.4HLA-DRB1, IFNG, IL6, TNF
22
Show member pathways
8.3HLA-DRB1, IFNG, IL4, TNF
23
Show member pathways
8.3IFNG, IL2, IL6, TNF
248.3IFNG, IL2, IL6, TNF
25
Show member pathways
8.3IFNG, IL2, IL6, TNF
268.3IFNG, IL2, IL6, TNF
27
Show member pathways
8.2IFNG, IL4, IL6, TNF
28
Show member pathways
8.2IFNG, IL2, IL4, TNF
29
Show member pathways
8.2IFNG, IL2, IL4, TNF
308.2IFNG, IL2, IL4, TNF
31
Show member pathways
8.1HLA-DRB1, IFNG, IL2, IL4
328.0IFNG, IL2, IL4, IL6
33
Show member pathways
8.0IFNG, IL2, IL4, IL6
34
Show member pathways
7.7IFNG, IL2, IL4, IL6, TNF
357.7IFNG, IL2, IL4, IL6, TNF
36
Show member pathways
7.5CD79A, HLA-DRB1, IFNG, IL2, IL4, TNF
37
Show member pathways
7.4CD79A, IFNG, IL2, IL4, IL6, TNF
387.4CD79A, IFNG, IL2, IL4, IL6, TNF
39
Show member pathways
7.3HLA-DRB1, IFNG, IL2, IL4, IL6, TNF
407.3HLA-DRB1, IFNG, IL2, IL4, IL6, TNF
41
Show member pathways
7.3HLA-DRB1, IFNG, IL2, IL4, IL6, TNF

GO Terms for genes affiliated with Microscopic Colitis

About this section

Biological processes related to Microscopic Colitis according to GeneCards Suite gene sharing:

(show all 32)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
2positive regulation of nitric oxide biosynthetic processGO:004542910.3IL6, TNF
3positive regulation of mononuclear cell migrationGO:007167710.2IL4, TNF
4negative regulation of lipid storageGO:001088810.2IL6, TNF
5negative regulation of fat cell differentiationGO:004559910.2IL6, TNF
6positive regulation of calcidiol 1-monooxygenase activityGO:006055910.0IFNG, TNF
7positive regulation of membrane protein ectodomain proteolysisGO:005104410.0IFNG, TNF
8positive regulation of B cell activationGO:005087110.0IL4, IL6
9positive regulation of T cell differentiationGO:004558210.0IL2, IL4
10extrinsic apoptotic signaling pathway in absence of ligandGO:00971929.9IL2, IL4
11positive regulation of tyrosine phosphorylation of Stat5 proteinGO:00425239.9IL2, IL4
12positive regulation of B cell proliferationGO:00308909.9IL2, IL4
13negative regulation of growth of symbiont in hostGO:00441309.9IFNG, TNF
14neutrophil apoptotic processGO:00017819.9IFNG, IL6
15antigen processing and presentationGO:00198829.8HLA-DRB1, IFNG
16protein import into nucleus, translocationGO:00000609.8IFNG, TNF
17positive regulation of osteoclast differentiationGO:00456729.7IFNG, TNF
18positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.5IL4, IL6, TNF
19positive regulation of MHC class II biosynthetic processGO:00453489.4IFNG, IL4
20positive regulation of chemokine biosynthetic processGO:00450809.4IFNG, IL4, TNF
21positive regulation of protein phosphorylationGO:00019349.3IL2, IL4, TNF
22cytokine-mediated signaling pathwayGO:00192219.2HLA-DRB1, IFNG, IL6
23adaptive immune responseGO:00022509.2CD79A, IFNG, IL2
24defense response to protozoanGO:00428329.1IFNG, IL4, IL6
25positive regulation of T cell proliferationGO:00421029.1IFNG, IL2, IL4
26positive regulation of isotype switching to IgG isotypesGO:00483049.0IFNG, IL2, IL4
27cellular response to lipopolysaccharideGO:00712228.8IFNG, IL6, TNF
28positive regulation of transcription, DNA-templatedGO:00458938.6IFNG, IL4, IL6, TNF
29response to drugGO:00424938.3IFNG, IL4, IL6, SLC6A4
30positive regulation of cell proliferationGO:00082847.9IFNG, IL2, IL4, IL6
31positive regulation of transcription from RNA polymerase II promoterGO:00459447.7IFNG, IL2, IL4, IL6, TNF
32immune responseGO:00069556.9HLA-DRB1, IFNG, IL2, IL4, IL6, MR1

Sources for Microscopic Colitis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet